Mebeverine Hydrochloride Ibs Morningside Healthcare (Mebeverine Hydrochloride)

Mebeverine Hydrochloride is an antispasmodic that acts on the gastrointestinal smooth muscle to relieve spasm‑related symptoms.

• Irritable Bowel Syndrome (IBS): reduces abdominal cramping and irregular bowel movements.
• Functional Bowel Disorder: alleviates pain and discomfort caused by abnormal gut motility.
• Spastic Colon: improves stool frequency and consistency by relaxing colonic muscles.

• Mebeverine Hydrochloride exerts a direct relaxant effect on gastrointestinal smooth muscle, likely by inhibiting calcium influx into muscle cells. This reduces intracellular calcium concentrations, leading to decreased muscle contractility and attenuation of spasm without significant anticholinergic activity.

Mebeverine Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Dry mouth: reduced salivation.
• Headache: transient cranial discomfort.
• Dizziness: light‑headed sensation.
• Abdominal cramps: temporary worsening of gut pain.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Severe skin eruption: Stevens‑Johnson‑type rash.
• Cardiac arrhythmia: irregular heartbeat reported rarely.
• Hepatic dysfunction: abnormal liver enzymes.
• Anaphylaxis: rapid onset of systemic allergic response.
• Persistent severe diarrhea: may indicate underlying infection.

Before initiating therapy, clinicians should consider several safety aspects.

• Assess renal function: adjust use in patients with severe renal impairment.
• Monitor hepatic status: use cautiously in liver disease.
• Review allergy history: avoid if hypersensitivity to mebeverine or excipients is known.
• Evaluate concomitant anticholinergic drugs: increased antispasmodic effect may occur.
• Counsel on symptom monitoring: advise patients to report persistent or worsening abdominal pain.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mebeverine may interact with other medications that affect gastrointestinal motility or share metabolic pathways.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure.
• Concurrent use of other smooth‑muscle relaxants (e.g., dicyclomine): risk of excessive antispasmodic effect.

Moderate Interactions (Monitor Closely)

• Antidepressants with anticholinergic properties (e.g., amitriptyline): may enhance dry‑mouth symptoms.
• Laxatives or antidiarrheals: could mask therapeutic response.
• Antacids containing aluminum or magnesium: may alter absorption.
• Herbal preparations (e.g., peppermint oil): potential additive GI effects.
• Diuretics: monitor electrolyte balance if dehydration occurs.